Weekly Intelligence · 9 articles

Vet Industry Intel: May 10 – May 16, 2026

High-signal veterinary industry stories triangulated from multiple sources, scored for relevance, and grouped by event type.

Leadership Changes (1) Regulatory & Policy (4) Products & Technology (4)

Leadership Changes

May 14, 2026 [9/10] gnews_nva

NVA Taps Public Market Veteran for CFO, Signaling IPO Readiness - BriefGlance

National Veterinary Associates (NVA) has appointed a public market veteran as its new Chief Financial Officer, signaling potential preparations for an initial public offering (IPO).

NVA

Regulatory & Policy

May 13, 2026 [8/10] fda_cvm

FDA conditionally approves drug for canine neuropathic pain - Veterinary Practice News

The FDA has granted conditional approval for a new drug aimed at treating canine neuropathic pain.

FDA · Veterinary Practice News

May 14, 2026 [8/10] fda_cvm

FDA issues no-objection letter for the first precision fermentation-derived animal protein for use in pet food - DVM360

The FDA issued a no-objection letter for the first precision fermentation-derived animal protein intended for use in pet food.

FDA · DVM360

May 13, 2026 [7/10] businesswire_vet

CDC confirms cat-to-human transmission of avian influenza - American Veterinary Medical Association

The CDC has confirmed the first known instance of cat-to-human transmission of avian influenza, as reported by the American Veterinary Medical Association.

CDC · American Veterinary Medical Association

May 15, 2026 [7/10] dvm360

Cat-to-human transmission of highly pathogenic avian influenza virus confirmed - DVM360

DVM360 reported the confirmed cat-to-human transmission of the highly pathogenic avian influenza virus, highlighting potential zoonotic risks relevant to veterinary professionals.

DVM360

Products & Technology

May 12, 2026 [9/10] fda_cvm

Orion Animal Health receives US FDA approval for Tessie® (tasipimidine oral solution) for the treatment of noise aversion and separation anxiety in dogs - Yahoo Finance

Orion Animal Health has received US FDA approval for Tessie (tasipimidine oral solution) to treat noise aversion and separation anxiety in dogs.

Orion Animal Health · US FDA

May 12, 2026 [8/10] fda_cvm

Orion Animal Health receives US FDA approval for Tessie® - GlobeNewswire

Orion Animal Health has received US FDA approval for its Tessie product.

Orion Animal Health · FDA · GlobeNewswire

May 12, 2026 [7/10] fda_cvm

Hill's Pet Nutrition and Bond Pet Foods Receive FDA No-Objection Letter for First Animal Protein Produced via Precision Fermentation for Pet Food - PR Newswire

Hill's Pet Nutrition and Bond Pet Foods received an FDA no-objection letter for the first animal protein produced via precision fermentation for use in pet food.

Hill's Pet Nutrition · Bond Pet Foods · FDA · PR Newswire

May 15, 2026 [7/10] fda_cvm

FDA Clears Animal Protein Ingredient Developed By Hill's Pet Nutrition - ESM Magazine

The FDA has cleared a new animal protein ingredient developed by Hill's Pet Nutrition for use in pet food products.

Hill's Pet Nutrition · FDA · ESM Magazine

Most-mentioned this week

NVA (1)